Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study

BACKGROUND: The Toronto hepatocellular carcinoma (HCC) risk index (THRI) was developed to predict HCC in patients with cirrhosis. This study aimed to validate the THRI in a 10-year Asian cohort. METHODS: A total of 2836 patients with cirrhosis at the First Affiliated Hospital of Soochow University b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huixian, Zhu, Jinzhou, Xi, Liting, Xu, Chunfang, Wu, Airong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492382/
https://www.ncbi.nlm.nih.gov/pubmed/31039803
http://dx.doi.org/10.1186/s12957-019-1619-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492382/
https://www.ncbi.nlm.nih.gov/pubmed/31039803
http://dx.doi.org/10.1186/s12957-019-1619-3

Ejemplares similares